| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On November 26, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| 2003P-0366
|
| Amend approval for a nonprescription form of Prilosec (omeprazole magnesium)
|
|
|
|
|
| 2004D-0193
|
| Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
|
|
|
|
|
| 2004F-0066
|
| Filing of Food Additive Petition (FAP 4A4754) Food Additives Permitted in Food on an Interim Basis or in Contact With Food Pending Additional Study; Mannitol
|
|
|
|
|
| 2004N-0245
|
| Current Good Manufacturing Practice Regulations for Medicated Feeds, 21 CFR Part 225
|
|
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| EMC 11142
|
| Jessica Gates
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11143
|
| Kim Winn
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11144
|
| Jessica Dahlgren
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11145
|
| Katherine Miller
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11146
|
| Yudi Grant
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11147
|
| Susan Stump
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11148
|
| Danielle Pierce
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11149
|
| Carol J. Ortman
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11150
|
| Donna Ratliff
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11151
|
| Rebecca Allen
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 11152
|
| Rebecca Allen
|
| Vol #:
|
| 296
|
|
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
|
|
| EMC 1252
|
| Peg Bell
|
| Vol #:
|
| 5
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| EMC 197
|
| Kristen Stiegler
|
| Vol #:
|
| 3
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 465
|
| Melisa Worcester
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 466
|
| William Traylor
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 467
|
| Dawn
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 468
|
| Matt Morris
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 469
|
| Zal Lazkovic
|
| Vol #:
|
| 9
|
|
| | | | | | | | |
|
|
|
|
| EMC 470
|
| Smoothy
|
| Vol #:
|
| 9
|
|
|
|
|
| EMC 471
|
| Bridget Jones
|
| Vol #:
|
| 9
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| EMC 55
|
| Wayne and Kerry
|
| Vol #:
|
| 15
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
| |
|
| EMC 40
|
| Lilly Edwards
|
| Vol #:
|
| 5
|
|
|
|
|
| 2003P-0366
|
| Amend approval for a nonprescription form of Prilosec (omeprazole magnesium)
|
|
|
|
|
| EMC
1
|
| Procter & Gamble
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0193
|
| Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
|
|
|
|
|
| EMC
292
|
| HIV Medicine Association
|
| Vol #:
|
| 5
|
|
|
|
|
| 2004F-0066
|
| Filing of Food Additive Petition (FAP 4A4754) Food Additives Permitted in Food on an Interim Basis or in Contact With Food Pending Additional Study; Mannitol
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0245
|
| Current Good Manufacturing Practice Regulations for Medicated Feeds, 21 CFR Part 225
|
|
|
|
|
| ELET 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| EMC 1
|
| Robert B Innis, MD, PhD
|
| Vol #:
|
| 1
|
|
